Trials / Completed
CompletedNCT03596944
Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients
Primary Prevention With Statin and Incidence of Recurrent Myocardial Infarction and Cardiogenic Shock in Post-Acute Coronary Syndrome Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 145 (actual)
- Sponsor
- Tarumanagara University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effect of statin for primary prevention, towards lowering the incidence of recurrent myocardial infarction, cardiogenic shock and mortality in ACS patients.
Detailed description
Adult patients (≥ 18 years of age) with acute coronary syndrome which are diagnosed under ICD-10 coding of I24.9 were included in this study. The inclusion criteria are patients with primary diagnosis of I24.9 and with a complete record of prior medical and treatment history, electrocardiographic findings, cardiac marker results and outcomes. Participants were grouped into 2 groups - statin and non-statin based on prior history of statin use prior to ACS. Diagnosis of ACS was made based on clinical, electrocardiographic and cardiac marker findings found in the medical record. Data such as age, sex, ethnic, education, prior medical and treatment history, electrocardiographic and cardiac enzyme results as well as outcomes were collected from the patients' medical records. Outcomes of interest were defined as either recurrent myocardial infarction, cardiogenic shock, mortality or combinations of them as diagnosed in the medical records. GRACE and TIMI Scores are calculated to predict in hospital and future mortality rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Statin | Prescribed with statins for primary prevention |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-06-30
- Completion
- 2018-08-31
- First posted
- 2018-07-24
- Last updated
- 2018-09-12
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT03596944. Inclusion in this directory is not an endorsement.